Stay updated on Fevipiprant in Patients With Nasal Polyposis and Asthma Clinical Trial
Sign up to get notified when there's something new on the Fevipiprant in Patients With Nasal Polyposis and Asthma Clinical Trial page.

Latest updates to the Fevipiprant in Patients With Nasal Polyposis and Asthma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check18 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference2%
- Check25 days agoNo Change Detected
- Check46 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check61 days agoChange DetectedThe page has removed detailed descriptions of a Phase 3b study on fevipiprant for nasal polyps and asthma, while adding a brief mention of nasal polyps and a new revision number.SummaryDifference23%
- Check68 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check75 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
Stay in the know with updates to Fevipiprant in Patients With Nasal Polyposis and Asthma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fevipiprant in Patients With Nasal Polyposis and Asthma Clinical Trial page.